Helpline 07939 046 030
Freephone 0300 102 17 22*

07 September 2026

NF is Part of Her Story, Not the Whole Story

"I don't want it to get rid of my NF. I like having NF."

Those weren't the words I expected to hear from my twelve-year-old daughter.

She said them while taking part in a research study for children with Neurofibromatosis Type 1 (NF1), and they stopped me in my tracks. As her mum, every instinct has always been to wish this condition away. To protect her from the uncertainty, the hospital appointments and the challenges that come with it.

But Tora wasn't talking about the medical condition. She was talking about herself.

NF is part of who she is, but it isn't who she is. And perhaps that's the biggest lesson our family has learnt over the past twelve years.

When Tora was just a few weeks old, I noticed a single café-au-lait patch on her leg. As a GP, I recognised it as a possible early sign of NF. We were reassured it was probably nothing and even given antifungal cream "just in case". I remember crying as I applied that cream because, deep down, I knew it wasn't a fungal infection.

A few months later another café-au-lait patch appeared, and I pushed for a genetics referral. Almost a year later I stood by the living room window taking the call from the geneticist. Professionally, I spoke doctor to doctor. Emotionally, I was hoping they would tell me I had been wrong.

They didn’t.

As soon as I put the phone down, I cried.

As doctors, we understand genetics, probabilities and clinical pathways. Living with a diagnosis as a parent is entirely different. Suddenly it isn't a condition in a textbook. It's your child and an uncertain future.

Like many parents, I turned to Google. Every evening became another research paper, another forum and another worst-case scenario. I thought knowledge would bring reassurance. Instead, it left me exhausted.

Then I found Nerve Tumours UK.

I still remember speaking to Rosemary, one of the Specialist NF Advisors. She didn't dismiss my fears or make unrealistic promises. She simply listened, understood and helped me see beyond the diagnosis. That conversation marked the point where I stopped focusing on everything that might happen and started focusing on helping Tora live well.

Over the years, NF has become part of our normal. There have been MRI scans, ophthalmology appointments, physiotherapy, occupational therapy, speech and language therapy, and more hospital visits than I can remember. At one stage Tora was under nine different specialties. Thankfully, her optic pathway glioma has remained stable and her vision has been preserved.

Ironically, the biggest challenges haven't been the tumours.

For Tora, dyspraxia, dyslexia and dyscalculia have had the greatest impact on everyday life. School requires far more effort than people realise. As she's grown older, she's also become more aware of being different and has sometimes felt isolated. As a parent, those moments are often much harder to witness than any hospital appointment.

Yet despite it all, Tora continues to surprise me.

She has what she calls her own "aesthetic". She'll happily wear sunglasses indoors, create outfits nobody else would think of and has never been particularly interested in following the crowd.

One day another child made a comment about her NF. Before I had time to respond, Tora smiled and said, "That sounds like a you problem, not a me problem.” I couldn't have written a better response myself.

People often think resilience looks extraordinary. Living with NF has taught me that it usually looks much quieter. It looks like getting up for school when learning feels harder than it does for everyone else. It looks like another hospital appointment, another scan, another challenge, and simply carrying on.

Being both a GP and Tora's mum has also changed how I think about healthcare. Medicine rightly focuses on diagnosing and treating disease, but living with a lifelong condition has reminded me that health is much bigger than medicine alone. Confidence, purpose, relationships, movement, sleep and emotional wellbeing all shape how we experience our lives. That understanding led me towards lifestyle medicine and strengthened my belief that, while we can't always change a diagnosis, we can help people live well alongside it.

Earlier this year, Tora took part in a research study in Manchester investigating transcranial current stimulation to support learning and memory in children with NF1. Watching her volunteer made me incredibly proud and reminded me how important research is for the future of families living with NF. I often think back to the sentence that opened this article.

"I don't want it to get rid of my NF."

As a mother, I would still take this condition away in a heartbeat if I could. But I also understand what she meant. She doesn't see herself as broken. NF is one chapter of her story, not the title of it.

I'm incredibly grateful to Nerve Tumours UK, to Helen Swann, our Specialist NF Nurse in Wales, and to everyone who has supported our family over the years. Their knowledge, kindness and reassurance have made an enormous difference.

If there is one thing I hope people take away from our story, it is this: children with NF are so much more than their diagnosis. There are hospital appointments and uncertainty, but there is also laughter, hope, friendship, research and possibility.

And there is one remarkable twelve-year-old girl who reminds me every day that life is far bigger than any diagnosis.

Masterclasses in NF: Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Prof. Dr. Berthold Pemp

OT Sabine Koinig

Masterclasses in NF: Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Assoc. Prof. Dr. Gregor Kasprian

Dr. Hector Salvador, MD

Masterclasses in NF: The Patients’ Perspective: A Masterclass on NF Care Held by NF Patients

Masterclasses in NF: Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

 

Michel Kalamarides MD

Masterclasses in NF: Management Of Plexiform Neurofibromatosis in NF1- Rianne Oosterbrink, Justus L Groen, Karine Lascelles

Masterclasses in NF1: 1.Management Of Plexiform Neurofibromatosis in NF1

Rianne Oosterbrink MD

Justus L Groen MD

Karine Lascelles MD

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK